Tumor Imaging Metrics Core

The mission of the Tumor Imaging Metrics Core (TIMC) is to provide standardized, consistent, longitudinal radiological measurements to evaluate therapeutic response for DF/HCC clinical trials.

The TIMC -

• Makes reliable, quantitative, longitudinal measurements (such as RECIST, WHO, SWOG, standardized uptake value [SUV] etc.) of lesions from serial MRI, CT, PET, and PET/CT scan images
• Presents results of analyses on a password protected secure web-based report
• Provides an independent service, with verifiable measurement of treatment response for patients enrolled in cancer center trials
• Serves as a centralized, computerized resource to facilitate efficient internal or external auditing

Reliable tracking of changes in lesion size or metabolism is essential for clinical trials that use radiological measurements as surrogate endpoints. The Tumor Metrics Core provides a service for managing these images, making measurements in a routine, reliable, and centralized way, and making results available to investigators efficiently.